Phase II trial of cisplatin in the treatment of patients with advanced or reccurent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group study. - Thigpen,J.T.; Blessing,J.A.; Orr,J.W. (Cancer Treat Rep, 1986)